Question 1

What unit dose are you planning for this area, and how does your Dysport-to-Botox conversion ratio compare to published guidance?

Accepted Answer

A good answer sounds like: "For the glabella I typically use about 50 units of Dysport. The published conversion is roughly 2.5 Dysport units for every 1 Botox unit, so that is the equivalent of around 20 Botox units, though I adjust based on how your muscles respond." They should name a real number and explain the conversion without you having to prompt them. This matters because injectors who use a 1:1 swap from Botox to Dysport are either under-dosing you or creating unpredictable spread. If they cannot explain the conversion ratio at all, they have a knowledge gap specific to this product.

Question 2

How does your injection map for Dysport differ from Botox given its broader spread?

Accepted Answer

A good answer sounds like: "With Dysport I move my injection points further away from the brow and lid because it spreads about 20 to 30 percent further per point. That means I also need fewer injection sites to cover the same area, which is actually one of the benefits for a wide forehead." This matters because an injector who uses the same map for Dysport as Botox is not accounting for a fundamental property of the product, and that difference is one of the main reasons ptosis rates are higher in inexperienced hands with Dysport. If they say "I inject it the same way," that is a meaningful concern.

Question 3

Have you treated patients with similar anatomy to mine with Dysport, any results you'd flag?

Accepted Answer

A good answer is candid and specific: "Yes, I have treated a few patients with a similar low brow position to yours. I go more conservative on the lower forehead in those cases because Dysport's spread means you have less margin for error near the brow." Or, if your anatomy is straightforward, they should say so directly. This tells you they are assessing you as an individual rather than applying a generic plan. If they say "all anatomy responds the same" or seem not to have looked closely at your face, that is a clinical shortcut.

Question 4

What is your protocol if spread causes brow or lid ptosis?

Accepted Answer

A good answer sounds like: "For brow heaviness, we monitor it because it typically resolves on its own within four to six weeks as the toxin wears off. For true eyelid ptosis, where the lid itself droops over the eye, I prescribe apraclonidine eye drops which stimulate a muscle in the lid and give partial lift while it resolves." Ptosis, meaning the drooping of the brow or eyelid, is one of the more distressing short-term complications. Apraclonidine is a real prescription treatment for eyelid ptosis specifically. If they seem unfamiliar with it, or say "there is nothing to do but wait," that is a gap in their complication management knowledge.

Question 5

Do you stock apraclonidine eye drops for emergency ptosis management?

Accepted Answer

The answer should be yes, and they should be able to name the drug without hesitation. Apraclonidine, also known as Iopidine, works by stimulating a small muscle in the upper eyelid called Muller's muscle, partially lifting the lid while the toxin wears off. Any clinic performing periocular or forehead injections should have this on hand. If they say they will prescribe it if needed, or seem unfamiliar with the drug altogether, those are red flags for a practice that is not fully prepared for the complications of the treatments it offers.

Question 6

Will you mark the injection points before treating so I can understand the plan?

Accepted Answer

They should agree readily and without making you feel like you are being difficult. Marking sites before injecting is a sign of a methodical practitioner who is willing to be transparent about what they are doing and where. It also gives you a chance to ask questions before needles are involved. Resistance to this step, or being told "I do it by feel," suggests they are working from habit rather than a deliberate plan, which reduces both precision and your ability to give informed consent.

Stay informed